Lumify
Active Ingredient(s): Brimonidine TartrateFDA Approved: * December 22, 2017
Pharm Company: * BAUSCH AND LOMB INC
Category: Vision / Eye Health
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Lumify Overview
Brimonidine is a drug, used as eye drops under the brand names Alphagan and Alphagan-P to treat open-angle glaucoma or ocular hypertension, as a gel, Mirvaso, for facial skin redness in rosacea, and in tartrate formulation, beginning in July of 2018, as an ophthalmic vasoconstrictor, sold by Bausch and Lomb under the brand name Lumify, also as eye drops, in 0.025% solution.[citation needed] It acts via decreasing synthesis of aqueous humor, and increasing the amount that drain...
Read more Lumify DetailsDetails May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brimonidine
Recent Lumify Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Brimonidine Tartrate
- Drops: 0.2%
- Gel: 0.33%
- Solution: 0.15%, 0.2%
- Solution/drops: 0.025%, 0.1%, 0.10%, 0.15%, 0.2%, 0.20%, 0.5%, 0.50%
Other drugs which contain Brimonidine Tartrate or a similar ingredient: (8 results)
- ALPHAGAN Brimonidine1 discussion
- ALPHAGAN P Brimonidine1 discussion
- BRIMONIDINE 1 discussion
- MIRVASO Brimonidine
- BRIMONIDINE TARTRATE + TIMOLOL MALEATE
- BRINZOLAMIDE + BRIMONIDINE TARTRATE
- COMBIGAN Brimonidine Tartrate + Timolol Maleate2 discussions
- SIMBRINZA Brinzolamide + Brimonidine Tartrate2 discussions